Investment Rating - Maintain 'Outperform' rating for the company, indicating expected performance above the market benchmark over the next 12-18 months [4][9]. Core Views - Despite challenges in glyphosate and silicone sectors, the company achieved stable growth in 2024, supported by its growth and resource sectors [4][9]. - The earnings forecasts for 2025-2026 have been lowered due to the lack of recovery in agrochemical and silicone sectors, with new forecasts for 2027 introduced [4][9]. - The target price is maintained at 24.34 RMB, corresponding to a PE ratio of 14.5x for 2025, which is above the average of 11.5x for comparable companies, reflecting optimism about the dual main business elasticity [4][9]. Financial Summary - 2024 revenue is projected at 28.40 billion RMB, a slight increase of 0.41% year-on-year, with net profit attributable to shareholders at 1.60 billion RMB, up 14.33% [4][9]. - The fourth quarter of 2024 saw revenue of 6.35 billion RMB, a year-on-year increase of 1.70%, but a quarter-on-quarter decrease of 26.60%, with net profit of 287 million RMB, down 35.82% year-on-year and down 43.63% quarter-on-quarter [4][9]. - The company plans to focus on phosphate expansion and downstream fine products capacity in 2025, aiming to complete several key projects within the year [4][9]. Financial Projections - EPS for 2025-2027 is projected to be 1.68, 1.93, and 2.19 RMB respectively, with previous estimates for 2025-2026 being 2.01 and 2.25 RMB [4][9]. - The company aims to complete various projects, including 40,000 tons/year ultra-high purity electronic chemicals and electronic-grade hydrogen peroxide expansion projects [4][9]. - Significant profit increases are expected from phosphate and specialty chemicals sectors, demonstrating resilience from deep industry chain cultivation [4][9].

Investment Rating - The investment rating for the company is "Outperform the Market" and is maintained [2]. Core Views - The report highlights a 36.38% year-on-year decline in the company's net profit attributable to the parent company for 2024, driven by a decrease in product prices and increased convertible bond interest expenses [7]. - The company is expected to benefit from its overseas expansion and new material development, which are anticipated to drive growth in the coming years [7]. Financial Performance and Forecast - The company reported a revenue of 34.31 billion yuan in 2024, a slight decrease of 0.69% year-on-year [7]. - The projected revenues for 2025, 2026, and 2027 are 39.56 billion yuan, 43.59 billion yuan, and 47.16 billion yuan, respectively, indicating a growth rate of 15.3%, 10.2%, and 8.2% [6][12]. - The net profit for 2024 is forecasted at 1.92 billion yuan, with a significant recovery expected in 2025 at 3.06 billion yuan, reflecting a year-on-year growth of 59.5% [6][12]. - The company's earnings per share (EPS) are projected to be 0.43 yuan in 2024, increasing to 0.68 yuan in 2025 and further to 0.84 yuan in 2027 [6][12]. Product and Market Analysis - The report indicates that the company's high-performance rubber additives and multifunctional rubber additives had revenue changes of -5.76% and 6.34% respectively in 2024, with sales volumes increasing by 4.06% and 4.96% [7]. - The company is actively expanding its overseas production capacity, including a new rubber additive production base in Thailand [7]. - The acquisition of Bomi Technology is aimed at enhancing the company's competitiveness in the electronic chemicals sector, with a focus on polyimide materials [7]. Valuation and Peer Comparison - The report suggests a reasonable valuation range for the company at 12.24 to 13.60 yuan based on a price-to-earnings (PE) ratio of 18-20 times for 2025 [7]. - The company’s competitive position is strengthened by its significant market share in key products, such as over 60% in the global market for anti-scorching agents [7].